{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:21:37Z","timestamp":1781796097115,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.2353\/jmoldx.2006.060022","type":"journal-article","created":{"date-parts":[[2006,8,21]],"date-time":"2006-08-21T21:20:28Z","timestamp":1156195228000},"page":"412-419","source":"Crossref","is-referenced-by-count":75,"title":["Molecular Diagnosis of Mast Cell Disorders"],"prefix":"10.1016","volume":"8","author":[{"given":"Cem","family":"Akin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2353\/jmoldx.2006.060022_bib1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.med.55.091902.103822","article-title":"Systemic mastocytosis","volume":"55","author":"Akin","year":"2004","journal-title":"Annu Rev Med"},{"key":"10.2353\/jmoldx.2006.060022_bib2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00277-002-0575-z","article-title":"Mastocytosis: current concepts in diagnosis and treatment","volume":"81","author":"Escribano","year":"2002","journal-title":"Ann Hematol"},{"key":"10.2353\/jmoldx.2006.060022_bib3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0145-2126(01)00044-3","article-title":"Clinical and histopathological aspects of cutaneous mastocytosis","volume":"25","author":"Wolff","year":"2001","journal-title":"Leuk Res"},{"key":"10.2353\/jmoldx.2006.060022_bib4","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1046\/j.1365-2141.2003.04575.x","article-title":"Diagnosis and treatment of systemic mastocytosis: state of the art","volume":"122","author":"Valent","year":"2003","journal-title":"Br J Haematol"},{"key":"10.2353\/jmoldx.2006.060022_bib5","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/1097-0142(19880901)62:5<965::AID-CNCR2820620520>3.0.CO;2-M","article-title":"Significance of systemic mast cell disease with associated hematologic disorders","volume":"62","author":"Travis","year":"1988","journal-title":"Cancer"},{"key":"10.2353\/jmoldx.2006.060022_bib6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1210\/jcem-72-1-140","article-title":"Systemic mastocytosis presenting as osteoporosis: a clinical and histomorphometric study","volume":"72","author":"Chines","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.2353\/jmoldx.2006.060022_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2500\/108854100778249006","article-title":"Differential diagnosis of the patient with unexplained flushing\/anaphylaxis","volume":"21","author":"Metcalfe","year":"2000","journal-title":"Allergy Asthma Proc"},{"key":"10.2353\/jmoldx.2006.060022_bib8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"10.2353\/jmoldx.2006.060022_bib9","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1111\/1523-1747.ep12468942","article-title":"Pediatric mastocytosis","volume":"96","author":"Kettelhut","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.2353\/jmoldx.2006.060022_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/adc.86.5.315","article-title":"Paediatric mastocytosis","volume":"86","author":"Carter","year":"2002","journal-title":"Arch Dis Child"},{"key":"10.2353\/jmoldx.2006.060022_bib11","doi-asserted-by":"crossref","first-page":"47S","DOI":"10.1111\/1523-1747.ep12469034","article-title":"Hematologic aspects of mastocytosis: I: bone marrow pathology in adult and pediatric systemic mast cell disease","volume":"96","author":"Parker","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.2353\/jmoldx.2006.060022_bib12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0145-2126(01)00041-8","article-title":"Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis","volume":"25","author":"Sperr","year":"2001","journal-title":"Leuk Res"},{"key":"10.2353\/jmoldx.2006.060022_bib13","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0145-2126(01)00020-0","article-title":"Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders","volume":"25","author":"Schwartz","year":"2001","journal-title":"Leuk Res"},{"key":"10.2353\/jmoldx.2006.060022_bib14","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/00000478-199809000-00013","article-title":"Diagnostic value of immunostaining for tryptase in patients with mastocytosis","volume":"22","author":"Horny","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.2353\/jmoldx.2006.060022_bib15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0145-2126(01)00050-9","article-title":"Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis","volume":"25","author":"Escribano","year":"2001","journal-title":"Leuk Res"},{"key":"10.2353\/jmoldx.2006.060022_bib16","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1182\/blood.V91.8.2731.2731_2731_2736","article-title":"Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications","volume":"91","author":"Escribano","year":"1998","journal-title":"Blood"},{"key":"10.2353\/jmoldx.2006.060022_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.b.10072","article-title":"Immunophenotypic analysis of mast cells in mastocytosis: when and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA)","volume":"58","author":"Escribano","year":"2004","journal-title":"Cytometry B Clin Cytom"},{"key":"10.2353\/jmoldx.2006.060022_bib18","first-page":"9","article-title":"The biology of Kit in disease and the application of pharmacogenetics","volume":"114","author":"Akin","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.2353\/jmoldx.2006.060022_bib19","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S1357-2725(99)00078-3","article-title":"Early signaling pathways activated by c-Kit in hematopoietic cells","volume":"31","author":"Linnekin","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"10.2353\/jmoldx.2006.060022_bib20","first-page":"965","article-title":"The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others","volume":"142","author":"Galli","year":"1993","journal-title":"Am J Pathol"},{"key":"10.2353\/jmoldx.2006.060022_bib21","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/jmoldx.2006.060022_bib22","doi-asserted-by":"crossref","first-page":"31461","DOI":"10.1074\/jbc.C300186200","article-title":"Structure of a c-kit product complex reveals the basis for kinase transactivation","volume":"278","author":"Mol","year":"2003","journal-title":"J Biol Chem"},{"key":"10.2353\/jmoldx.2006.060022_bib23","doi-asserted-by":"crossref","first-page":"31655","DOI":"10.1074\/jbc.M403319200","article-title":"Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase","volume":"279","author":"Mol","year":"2004","journal-title":"J Biol Chem"},{"key":"10.2353\/jmoldx.2006.060022_bib24","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1021\/jm050231m","article-title":"Molecular modeling of wild-type and D816V c-Kit inhibition based on ATP-competitive binding of ellipticine derivatives to tyrosine kinases","volume":"48","author":"Vendome","year":"2005","journal-title":"J Med Chem"},{"key":"10.2353\/jmoldx.2006.060022_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1468-3083.2004.00830.x","article-title":"Cutaneous mastocytosis in children: a clinical analysis of 71 cases","volume":"18","author":"Kiszewski","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.2353\/jmoldx.2006.060022_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1440-0960.2001.00466.x","article-title":"Presentation of cutaneous mastocytosis in 173 children","volume":"42","author":"Hannaford","year":"2001","journal-title":"Australas J Dermatol"},{"key":"10.2353\/jmoldx.2006.060022_bib27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archderm.1963.01590140008002","article-title":"The natural course of urticaria pigmentosa. Analysis and follow-up of 112 cases","volume":"87","author":"Caplan","year":"1963","journal-title":"Arch Dermatol"},{"key":"10.2353\/jmoldx.2006.060022_bib28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000085563","article-title":"Clonality and molecular pathogenesis of mastocytosis","volume":"114","author":"Akin","year":"2005","journal-title":"Acta Haematol"},{"key":"10.2353\/jmoldx.2006.060022_bib29","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0145-2126(01)00023-6","article-title":"Slowly progressive systemic mastocytosis with high mast-cell burden and no evidence of a non-mast-cell hematologic disorder: an example of a smoldering case?","volume":"25","author":"Akin","year":"2001","journal-title":"Leuk Res"},{"key":"10.2353\/jmoldx.2006.060022_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000048185","article-title":"Smouldering mastocytosis: a novel subtype of systemic mastocytosis with slow progression","volume":"127","author":"Valent","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.2353\/jmoldx.2006.060022_bib31","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood-2002-01-0203","article-title":"Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene","volume":"100","author":"Yavuz","year":"2002","journal-title":"Blood"},{"key":"10.2353\/jmoldx.2006.060022_bib32","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jaci.2005.02.030","article-title":"Analysis of the lineage relationship between mast cells and basophils using the c-kit D816V mutation as a biologic signature","volume":"115","author":"Kocabas","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.2353\/jmoldx.2006.060022_bib33","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2003-11-3816","article-title":"A novel form of mastocytosis associated with a transmembrane c-Kit mutation and response to imatinib","volume":"103","author":"Akin","year":"2004","journal-title":"Blood"},{"key":"10.2353\/jmoldx.2006.060022_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrfmmm.2004.08.015","article-title":"Detection of an activating c-kit mutation by real-time PCR in patients with anaphylaxis","volume":"572","author":"Lawley","year":"2005","journal-title":"Mutat Res"},{"key":"10.2353\/jmoldx.2006.060022_bib35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9440(10)63870-9","article-title":"One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes","volume":"162","author":"Sotlar","year":"2003","journal-title":"Am J Pathol"},{"key":"10.2353\/jmoldx.2006.060022_bib36","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N Engl J Med"},{"key":"10.2353\/jmoldx.2006.060022_bib37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000085559","article-title":"Molecular classification and pathogenesis of eosinophilic disorders: 2005 update","volume":"114","author":"Gotlib","year":"2005","journal-title":"Acta Haematol"},{"key":"10.2353\/jmoldx.2006.060022_bib38","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2141.2005.05863.x","article-title":"Multilineage involvement of the fusion gene in patients with FIP1L1\/PDGFRA-positive hypereosinophilic syndrome","volume":"132","author":"Robyn","year":"2006","journal-title":"Br J Haematol"},{"key":"10.2353\/jmoldx.2006.060022_bib39","first-page":"871","article-title":"FIP1L1-PDGFRA and c-kit D816V mutation-based clonality studies in systemic mast cell disease associated with eosinophilia","volume":"89","author":"Tefferi","year":"2004","journal-title":"Haematologica"},{"key":"10.2353\/jmoldx.2006.060022_bib40","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1182\/blood-2003-01-0006","article-title":"Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness","volume":"101","author":"Klion","year":"2003","journal-title":"Blood"},{"key":"10.2353\/jmoldx.2006.060022_bib41","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1182\/blood-2003-05-1627","article-title":"CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy","volume":"102","author":"Pardanani","year":"2003","journal-title":"Blood"},{"key":"10.2353\/jmoldx.2006.060022_bib42","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.thj.6200348","article-title":"Chronic myelogenous leukemia with acquired c-kit activating mutation and transient bone marrow mastocytosis","volume":"5","author":"Cairoli","year":"2004","journal-title":"Hematol J"},{"key":"10.2353\/jmoldx.2006.060022_bib43","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.leukres.2005.04.004","article-title":"Ph-chromosome-positive chronic myeloid leukemia with associated bone marrow mastocytosis","volume":"29","author":"Agis","year":"2005","journal-title":"Leuk Res"},{"key":"10.2353\/jmoldx.2006.060022_bib44","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1182\/blood-2005-09-3640","article-title":"Prognostic impact of c-KIT mutations in core binding factor leukemias. An Italian retrospective study","volume":"107","author":"Cairoli","year":"2006","journal-title":"Blood"},{"key":"10.2353\/jmoldx.2006.060022_bib45","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/sj.leu.2403870","article-title":"Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia","volume":"19","author":"Goemans","year":"2005","journal-title":"Leukemia"},{"key":"10.2353\/jmoldx.2006.060022_bib46","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1182\/blood-2005-08-3408","article-title":"KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group","volume":"107","author":"Shimada","year":"2006","journal-title":"Blood"},{"key":"10.2353\/jmoldx.2006.060022_bib47","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1182\/blood-2005-04-1466","article-title":"KIT-D816 mutations in AML1-ETO positive AML are associated with impaired event-free and overall survival","volume":"107","author":"Schnittger","year":"2006","journal-title":"Blood"},{"key":"10.2353\/jmoldx.2006.060022_bib48","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0145-2126(02)00168-6","article-title":"Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria","volume":"27","author":"Valent","year":"2003","journal-title":"Leuk Res"},{"key":"10.2353\/jmoldx.2006.060022_bib49","first-page":"139","article-title":"Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors","volume":"295","author":"Buchdunger","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.2353\/jmoldx.2006.060022_bib50","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood.V99.5.1741","article-title":"The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations","volume":"99","author":"Ma","year":"2002","journal-title":"Blood"},{"key":"10.2353\/jmoldx.2006.060022_bib51","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0301-472X(03)00112-7","article-title":"Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit","volume":"31","author":"Akin","year":"2003","journal-title":"Exp Hematol"},{"key":"10.2353\/jmoldx.2006.060022_bib52","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V96.3.925","article-title":"Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor","volume":"96","author":"Heinrich","year":"2000","journal-title":"Blood"},{"key":"10.2353\/jmoldx.2006.060022_bib53","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2003-08-2798","article-title":"Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome","volume":"103","author":"Klion","year":"2004","journal-title":"Blood"},{"key":"10.2353\/jmoldx.2006.060022_bib54","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1182\/blood-2005-04-1568","article-title":"Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation","volume":"106","author":"Gotlib","year":"2005","journal-title":"Blood"},{"key":"10.2353\/jmoldx.2006.060022_bib55","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1182\/blood-2005-10-3969","article-title":"Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in the majority of patients with systemic mastocytosis","volume":"108","author":"Shah","year":"2006","journal-title":"Blood"},{"key":"10.2353\/jmoldx.2006.060022_bib56","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood-2005-07-3022","article-title":"PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects","volume":"107","author":"Gleixner","year":"2006","journal-title":"Blood"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157810603224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157810603224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T23:38:32Z","timestamp":1587166712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157810603224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S1525157810603224"],"URL":"https:\/\/doi.org\/10.2353\/jmoldx.2006.060022","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}